| Bid Price | 175.50p | High Price | 180.50p |
|---|
| Ask Price | 179.50p | Low Price | 173.41p |
|---|
| Open Price | 177.00p | Spread | 2.23% |
|---|
| Prev Close | 178.00p | Volume | 121,491 |
|---|
Hemogenyx Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| May 16, 2025 | 177.00 | 180.50 | 173.41 | 177.50 | 121,491 |
| May 15, 2025 | 183.73 | 183.73 | 177.00 | 178.00 | 13,350 |
| May 14, 2025 | 180.00 | 180.50 | 178.35 | 178.75 | 301,592 |
| May 13, 2025 | 180.50 | 183.00 | 178.00 | 179.00 | 35,870 |
| May 12, 2025 | 182.60 | 184.78 | 180.50 | 182.75 | 6,990 |
Hemogenyx Pharmaceuticals PLC Information
| Name | Hemogenyx Pharmaceuticals PLC | Index | |
|---|
| ISIN | GB00BQVXM815 | Epic | HEMO |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 1,500 | Trading Status | Closed |
|---|
| Shares in Issue | 4.09 m | Prev Close | 178.00p |
|---|
| PE Ratio | | Market Cap | £7.27 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£1.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.572635 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.724158 | Quick Ratio | 0.140709 |
|---|
Hemogenyx Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 14/05/25 | PLAC | Vladislav Sandler | CEO | 250,000 @ £1.81 | £451,250.00 |
| 30/01/20 | PLAC | Peter Redmond | NED | 555,556 @ £0.02 | £10,000.00 |
| 03/07/19 | TIN | Vladislav Sandler | CEO | 1,066,667 @ £0.00 | £0.00 |
| 12/02/18 | BUY | Adrian Thorpe Beeston | RES | 200,000 @ £0.02 | £4,200.00 |
| 07/02/18 | BUY | Vladislav Sandler | CEO | 26,800 @ £0.02 | £635.00 |
| 11/10/17 | BUY | Adrian Thorpe Beeston | RES | 400,000 @ £0.03 | £11,840.00 |
| 10/10/17 | BUY | Peter Redmond | NED | 155,000 @ £0.03 | £4,859.00 |
| 10/10/17 | BUY | Adrian Thorpe Beeston | RES | 317,683 @ £0.03 | £9,848.00 |
Hemogenyx Pharmaceuticals PLC News
